Data / Form D filings / Ambrosia Biosciences Inc.
Ambrosia Biosciences Inc.: Form D filings
Ambrosia Biosciences Inc., a biotechnology company in Boulder, CO, filed 2 Form D notices with the SEC in 2024. The latest, on August 20, 2024, reports $16 million sold of a $25 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1941 PEARL STREET, SUITE 300, Boulder, CO, 80302
- Phone
- (303) 351-5800
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2032941
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 20, 2024 | Amendment | $25,000,000 | $15,955,000 | $9,045,000 | 7 | Jul 23, 2024 | sec.gov |
| Aug 7, 2024 | New notice | $25,000,000 | $12,500,000 | $12,500,000 | 6 | Jul 23, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David S. Snitman | Director | |
| William S. Marshall | Director | |
| Nicholas Traggis | Executive Officer, Director | |
| Kyle Lefkoff | Director | |
| John S. Orwin | Director |
Other biotechnology companies in Colorado that filed recently
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
- Shiverbright Technologies, Inc. $200,000 · Aug 7, 2026
Every Form D from the week of Aug 19, 2024 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Ambrosia Biosciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.